These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 20331516

  • 1. Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report.
    Grenda R, Jarmużek W, Piątosa B, Rubik J.
    Pediatr Transplant; 2011 Sep; 15(6):E121-5. PubMed ID: 20331516
    [Abstract] [Full Text] [Related]

  • 2. Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome.
    Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, Dötsch J.
    Nephrol Dial Transplant; 2012 May; 27(5):1910-5. PubMed ID: 22076431
    [Abstract] [Full Text] [Related]

  • 3. Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.
    Rodríguez-Ferrero M, Ampuero J, Anaya F.
    Transplant Proc; 2009 May; 41(6):2406-8. PubMed ID: 19715934
    [Abstract] [Full Text] [Related]

  • 4. Rituximab treatment for recurrence of nephrotic syndrome in a pediatric patient after renal transplantation for congenital nephrotic syndrome of Finnish type.
    Chaudhuri A, Kambham N, Sutherland S, Grimm P, Alexander S, Concepcion W, Sarwal M, Wong C.
    Pediatr Transplant; 2012 Aug; 16(5):E183-7. PubMed ID: 21672106
    [Abstract] [Full Text] [Related]

  • 5. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recurrence of nephrotic proteinuria in children with focal segmental glomerulosclerosis after renal transplantation treated with plasmapheresis and immunoadsorption: case reports.
    Fencl F, Simková E, Vondrák K, Janda J, Chadimová M, Stejskal J, Seeman T.
    Transplant Proc; 2007 Dec; 39(10):3488-90. PubMed ID: 18089416
    [Abstract] [Full Text] [Related]

  • 8. Rituximab in steroid-dependent nephrotic syndrome.
    El Koumi M.
    Iran J Kidney Dis; 2013 Nov; 7(6):502-6. PubMed ID: 24241100
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intravenous cyclosporine therapy in recurrent nephrotic syndrome after renal transplantation in children.
    Salomon R, Gagnadoux MF, Niaudet P.
    Transplantation; 2003 Mar 27; 75(6):810-4. PubMed ID: 12660507
    [Abstract] [Full Text] [Related]

  • 11. Rituximab treatment for adults with refractory nephrotic syndrome: a single-center experience and review of the literature.
    Kisner T, Burst V, Teschner S, Benzing T, Kurschat CE.
    Nephron Clin Pract; 2012 Mar 27; 120(2):c79-85. PubMed ID: 22286071
    [Abstract] [Full Text] [Related]

  • 12. Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab.
    Hristea D, Hadaya K, Marangon N, Buhler L, Villard J, Morel P, Martin PY.
    Transpl Int; 2007 Jan 27; 20(1):102-5. PubMed ID: 17181660
    [Abstract] [Full Text] [Related]

  • 13. Rituximab is not a "magic drug" in post-transplant recurrence of nephrotic syndrome.
    Grenda R, Jarmużek W, Rubik J, Piątosa B, Prokurat S.
    Eur J Pediatr; 2016 Sep 27; 175(9):1133-1137. PubMed ID: 27364906
    [Abstract] [Full Text] [Related]

  • 14. Rituximab for post-transplant recurrences of FSGS.
    Bayrakci US, Baskin E, Sakalli H, Karakayali H, Haberal M.
    Pediatr Transplant; 2009 Mar 27; 13(2):240-3. PubMed ID: 18822107
    [Abstract] [Full Text] [Related]

  • 15. Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis.
    Gossmann J, Scheuermann EH, Porubsky S, Kachel HG, Geiger H, Hauser IA.
    Transpl Int; 2007 Jun 27; 20(6):558-62. PubMed ID: 17433091
    [Abstract] [Full Text] [Related]

  • 16. Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.
    Ehrich JH, Geerlings C, Zivicnjak M, Franke D, Geerlings H, Gellermann J.
    Nephrol Dial Transplant; 2007 Aug 27; 22(8):2183-93. PubMed ID: 17504846
    [Abstract] [Full Text] [Related]

  • 17. Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.
    Chikamoto H, Hattori M, Kuroda N, Kajiho Y, Matsumura H, Fujii H, Ishizuka K, Hisano M, Akioka Y, Nozu K, Kaito H, Shimizu M.
    Pediatr Transplant; 2012 Nov 27; 16(7):E286-90. PubMed ID: 22129369
    [Abstract] [Full Text] [Related]

  • 18. [Treatment of children with steroid-dependent nephrotic syndrome with rituximab].
    Huang J, Du J, Wang S, Xiao L, Zhao X.
    Zhonghua Er Ke Za Zhi; 2014 Jul 27; 52(7):521-4. PubMed ID: 25224058
    [Abstract] [Full Text] [Related]

  • 19. Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.
    Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.
    Transplantation; 2009 Aug 15; 88(3):417-20. PubMed ID: 19667947
    [Abstract] [Full Text] [Related]

  • 20. Long-term Cyclosporine A (Sandimmun) therapy for steroid resistant nephrotic syndrome in children.
    Sancewicz-Pach K, Słowiaczek E, Kwinta-Rybicka J, Wilkosz K, Drozdz D, Nowak J.
    Przegl Lek; 1996 Aug 15; 53(4):365-8. PubMed ID: 8711193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.